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Relationships Among IL-6, TNF-α,
TNF- , Adipokines, Vitamin D and Chronic
Periodontitis
Abstract

Objectives
to explore relationships among serum adipokines, vitamin D, clinical and microbial parameters of chronic
periodontitis before and after treatment.

Methods
weight, height and smoking status were recorded for 56 patients with chronic periodontitis. Plaque,
gingivitis, bleeding on probing (BOP), suppuration, pocket depth (PD) and attachment level (AL) were
measured at all teeth present. Subgingival biofilm samples from each tooth were analyzed for levels of 40
bacterial species using checkerboard DNA-DNA hybridization. Serum levels of interleukin 6 (IL-6), tumor
necrosis factor α (TNF-α), adiponectin, leptin, resistin and vitamin D were measured at baseline. Sample
collection was then performed in a subset of the population 6 months post-therapy (n=17). Serum
samples were analyzed using ELISA and immunoassays. Differences in clinical, microbial and serum
factors among groups were sought using the Mann-Whitney test. Correlations among factors were
evaluated using regression analysis. Effects of therapy were sought using the Wilcoxon signed ranks test

Results
There were positive correlations between adiponectin/vitamin D and between IL-6/leptin; negative
correlations between IL-6/vitamin D, and leptin/vitamin D, but no associations between serum analytes
and clinical or microbial parameters. Gender and BMI were associated with levels of adipokines.
Periodontal therapy improved clinical and microbiological parameters, but did not influence the levels of
serum analytes.

Conclusions
Adipokines and IL-6 levels were affected by gender and BMI. Serum analytes were not influenced by
periodontal therapy.
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Abstract
Objectives—to explore relationships among serum adipokines, vitamin D, clinical and microbial
parameters of chronic periodontitis before and after treatment.
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Methods—weight, height and smoking status were recorded for 56 patients with chronic
periodontitis. Plaque, gingivitis, bleeding on probing (BOP), suppuration, pocket depth (PD) and
attachment level (AL) were measured at all teeth present. Subgingival biofilm samples from each
tooth were analyzed for levels of 40 bacterial species using checkerboard DNA-DNA
hybridization. Serum levels of interleukin 6 (IL-6), tumor necrosis factor ! (TNF-!), adiponectin,
leptin, resistin and vitamin D were measured at baseline. Sample collection was then performed in
a subset of the population 6 months post-therapy (n=17). Serum samples were analyzed using
ELISA and immunoassays. Differences in clinical, microbial and serum factors among groups
were sought using the Mann-Whitney test. Correlations among factors were evaluated using
regression analysis. Effects of therapy were sought using the Wilcoxon signed ranks test
Results—There were positive correlations between adiponectin/vitamin D and between IL-6/
leptin; negative correlations between IL-6/vitamin D, and leptin/vitamin D, but no associations
between serum analytes and clinical or microbial parameters. Gender and BMI were associated
with levels of adipokines. Periodontal therapy improved clinical and microbiological parameters,
but did not influence the levels of serum analytes.
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Conclusions—Adipokines and IL-6 levels were affected by gender and BMI. Serum analytes
were not influenced by periodontal therapy.
Keywords
adipokines; cytokines; calcitriol; periodontitis; subgingival scaling; biofilm; microbiota

INTRODUCTION
Periodontal diseases are initiated by a consortia of oral bacteria that elicit local inflammatory
responses that lead to bleeding on probing, loss of periodontal attachment, bone and tooth
loss.1 They have been linked to systemic conditions, including heart disease 2, diabetes 3,
obesity 4 and metabolic syndrome.5 The association between periodontal diseases and these
systemic conditions seems to be due to a low grade inflammatory burden that links them
through a common pathophysiological mechanism. Conceivably, locally secreted cytokines
Correspondence: Flavia R. F. Teles Department of Periodontology, The Forsyth Institute 245 First Street, Cambridge, MA 02142
Phone: 617-892-8562 Fax: 617-262-4021 fteles@forsyth.org.
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and periodontal pathogens can enter into the bloodstream and contribute to damage
elsewhere in the body and there appears to be some evidence for that burden.6-9
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Tumor necrosis factor ! (TNF-!) and interleukin 6 (IL-6) are key cytokines in the initiation
and maintenance of systemic inflammation which have been implicated in progression and
severity of periodontitis.10, 11 In addition, higher serum levels of these cytokines have been
observed in periodontitis patients than in periodontally healthy individuals.9, 12-15.
Leptin, adiponectin and resistin are adipokines that are secreted primarily by adipose tissues,
but also produced by monocytes and macrophages and are able to directly influence
inflammation.16 Leptin regulates T lymphocyte proliferation, activation and cytokine
production and elevated levels are present in infection and inflammation17, 18. Resistin
levels increase upon endotoxin exposure.19 Adiponectin is associated with modulation of
inflammatory responses, via attenuation of TNF-! effects 20, inhibition of nuclear factor "B
(NF-"B), inhibition of IL-6 production and induction of anti-inflammatory cytokines IL-10
and IL1 receptor antagonist. 21
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Altered adipokine levels have been observed in systemic inflammatory conditions, including
inflammatory bowel disease (IBD) and rheumatoid arthritis.22 Little is known regarding the
potential association between adipokines and chronic periodontitis in systemically healthy
individuals. 23-25 In addition, studies that investigated the effects of periodontal treatment on
serum levels of adipokines, TNF-! and IL-6 in such patients have shown conflicting
results. 9, 15, 26-30
Vitamin D has an important role in bone growth and maintenance, which might be beneficial
for maintaining periodontal health. Recently, it has been suggested to have positive effects
on periodontal diseases, tooth loss and gingival inflammation not through its effects on bone
metabolism, but through anti-inflammatory mechanisms.31 Hence, adequate serum values of
Vitamin D could be important in the prevention and treatment of periodontal diseases.
The primary goal of this exploratory study was to examine relationships among serum levels
of IL6, TNF-!, adipokines, vitamin D and clinical and microbial parameters of chronic
periodontitis. The secondary objective of the present investigation was to assess the effects
of therapy on the levels of those serum analytes before and after non-surgical periodontal
therapy.

MATERIAL AND METHODS
Subject population
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The subject population consisted of 56 subjects with chronic periodontitis. The inclusion and
exclusion criteria were as follows:
Inclusion criteria—> 20 years of age, > 15 natural teeth, > 5% sites (approximately 8
sites) with pocket depth > 4 mm and/or 5% sites with attachment level > 4 mm and
willingness and ability to sign informed consent and overall systemic health as determined
upon completion of a medical questionnaire.
Exclusion criteria—Pregnancy or nursing, periodontal or antibiotic therapy in the
previous 3 months, any systemic condition which might influence the course of periodontal
disease or treatment (e.g. diabetes, AIDS), any systemic condition which requires antibiotic
coverage for routine periodontal procedures (e.g. heart conditions, joint replacements).

J Periodontol. Author manuscript; available in PMC 2013 September 01.
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Attempts were made to recruit approximately equal numbers of males and females. In
addition, subjects of any racial/ethnic group were accepted for the study, which was
performed between September 2003 and April 2008. All subjects were recruited at The
Forsyth Institute. The study was approved by The Forsyth Institute Institutional Review
Board and all subjects signed informed consent prior to entering the study.
Clinical monitoring and Periodontal Therapy
After determination of suitability and obtaining informed consent, subjects entered the
study. Prior to clinical monitoring visit, height and weight were recorded for the calculation
of the body mass index (BMI). Subjects were clinically monitored at baseline and 6 months
after periodontal therapy. Clinical measurements were taken at 6 sites per tooth
(mesiobuccal, buccal, distobuccal, distolingual, lingual, and mesiolingual) for all teeth
excluding third molars (a maximum of 168 sites per subject) as previously described.32 The
clinical parameters were measured in the following order: 1) gingival redness (0 or 1); 2)
plaque accumulation (0 or 1) 3) pocket depth (mm); 4) attachment level (mm); 5) bleeding
on probing (0 or 1); 6) suppuration (0 or 1).
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Pocket depth and attachment level measurements were made to the nearest mm using a
North Carolina periodontal probe. Pocket depth and attachment level measurements were
measured twice and the average of the pair of measurements was used for analysis. All
clinical data were recorded on data sheets and entered into a computer using a prompted data
entry program. Subgingival plaque samples were taken prior to the clinical measurements.
The same calibrated examiner took clinical measurements and samples at both monitoring
visits for a given subject.
After the initial monitoring and sampling, all subjects received scaling and root planing
(SRP) at four visits (one quadrant per visit), using manual curettes and ultrasonic devices
and also received oral hygiene instructions. All subjects received maintenance subgingival
scaling at 3 months. Clinical parameters and subgingival biofilm samples were collected
again 6 months after treatment.
Microbiological sample taking and enumeration of organisms
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After removal of supragingival plaque, individual subgingival plaque samples were taken
separately from the mesio-buccal aspect of up to 28 teeth in each subject at entry and at the
6 months post-treatment visit. Samples were taken using individual sterile Gracey curettes
and were evaluated for their content of 40 subgingival species using checkerboard DNADNA hybridization.33, 34 Each sample was placed in individual tubes containing 0.15 ml TE
(10 mM Tris-HCL, 0.1 mM EDTA, pH 7.6). 0.15 ml of freshly-prepared 0.5 M NaOH was
added. The samples were boiled for 5 min and neutralized using 0.8 ml of 5 M ammonium
acetate and placed into the extended slots of a Minislot‡ and then concentrated onto a
positively charged nylon membrane§ by vacuum and fixed to the membrane by exposure to
ultraviolet light followed by baking at 120°C for 20 min. The counts of the 40 species in
each sample were determined using checkerboard DNA-DNA hybridization.
Serum samples and analytes
Serum samples were collected at baseline and 6 months after periodontal therapy. Samples
were analyzed at the Harvard Catalyst Central Laboratory (Harvard Medical School, Boston,
MA) for their levels of adiponectin, leptin, resistin, IL-6, TNF-! and vitamin D. ELISA was
used to measure levels of adiponectinII , resistin¶ and TNF-!¶. Radioimmunoassays were
‡Immunetics, Cambridge MA.
§Roche, Indianapolis, IN.
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employed to assess levels of leptin# and vitamin D**. IL-6 was measured using a
chemiluminescent immunoassay††. The dynamic ranges of the assays were as follows: 0.10
to 24 ug/mL for adiponectin, 0.1-10 ng/mL for leptin, 0.21 -50 ng/mL for resistin, 1.9 6.5
pg/mL for IL-6, 0.106-16 pg/mL for TNF-! and 1.5-100 ng/mL for vitamin D.
Data Evaluation
Clinical parameters including plaque index, gingival index, % of sites with bleeding on
probing and suppuration as well as mean pocket depth and attachment level were computed
for each subject averaged within a subject and then averaged across subjects. In the same
fashion, counts of each bacterial species were determined at each sampled site, averaged
within a subject and then averaged across subjects.
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Relationships among serum analytes were sought using the Spearman correlation coefficient
rho (r). Significant correlations were sought using a t statistic. Measures of periodontal
disease severity (PD, CAL, %BOP) were used to stratify the population into tertiles and
search for associations between periodontal parameters and the serum biomarkers tested.
Differences in clinical, microbial and serological parameters among groups were sought
using the Kruskal-Wallis and the Chi-square test. The same approach was used to search for
those associations based on tertiles of the distribution for each of the serum analytes.
Multiple linear regression was used to assess the value of explanatory variables (gender,
BMI, age as well as serum and clinical variables) in predicting the response of selected
outcomes (adiponectin, IL-6, leptin, vitamin. D, resistin and TNF-!). The effects of
periodontal treatment on clinical and microbial parameters as well as on serum analytes
were sought using the Wilcoxon signed ranks test. Because of the exploratory nature of the
present study no attempts were made to correct for multiple comparisons.

RESULTS
Table 1 presents the baseline clinical parameters, as well as levels of serum analytes of the
56 subjects enrolled in the study. The overall mean PD and CAL were 3.2 mm and 3.6 mm,
respectively. Males represented 53% of the subject population and 49% of enrolled subjects
were current smokers. BMI values ranged from 15 to 63 kg/m2.
Figure 1 shows that positive correlations were observed between IL-6 and leptin (r=0.50,
p<0.001) and adiponectin and vitamin D (r=0.38, p<0.01). Negative correlations were
observed between IL-6 and vitamin D (p=-0.41, p<0.01) and leptin and vitamin D (p=-0.39,
p<0.01). Weak correlations were observed between serum analytes and mean clinical
parameters (-0.25.>r <0.19; p>0.05; data not shown).
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In order to explore relationships between serum biomarkers and the periodontal condition,
periodontitis subjects were divided into tertiles according to mean PD (Table 2). There was
an increase in bleeding on probing (p=0.0001) and attachment level (p=0.0001) with greater
pocket depth A similar pattern was observed for levels of pathogenic bacterial species
including members of the “red complex”35, Tannerella forsythia (p=0.003), Porphyromonas
gingivalis (p=0.012) and Treponema denticola (p=0.05), as well as levels of Prevotella
nigrescens (p=0.005) and Eubacterium nodatum (p=0.003), members of the “orange
complex”. When levels of serum analytes were compared among the three groups,

IIALPCO Diagnostics Inc, Salem, NH.
¶R & D Systems, Minneapolis, MN.
#LINCO Research, St. Charles, MS.
**Diasorin, Inc., Stillwater, MN.
††Beckman Coulter, Fullerton, CA.
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difference in the serum factors were of smaller magnitude. The same analysis was
performed using CAL and % BOP as measures of disease severity. A similar lack of
relationship with serum factors was observed (data not shown).
Using the same approach to seek associations between increasing levels of serum factors or
BMI and clinical and microbial parameters, the study population was subset into tertiles
according to levels of adiponectin, resistin, leptin, IL-6, TNF-! and vitamin D, as well as
BMI. None of the clinical or microbial parameters were associated with any of the serum
analytes (p>0.05, data not shown). Associations were observed for adiponectin, leptin and
IL-6 with being female. Leptin was associated with increased levels of IL-6 and BMI.
Finally, increased BMI was associated with higher levels of leptin (Table 3).
Using multiple linear regression, it was observed that the best predictors for adiponectin
levels were gender (female), BMI (lower) and increasing age (p=0.000078, r2= 0.278). For
leptin levels, the best predictors were gender (female) and BMI (higher) (p=0.000001, r2=
0.789). BMI was the only significant predictor for IL-6 (p=0.00074, r2= 0.195) and Vitamin
D (p=0.03735, r2= 0.209).
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The effects of periodontal therapy on serum analytes, clinical parameters and the
subgingival microbiota are shown in Fig. 3. Seventeen patients were examined at 6 months
post therapy. There were essentially no differences between pre and post treatment levels of
any of the serum analytes, although a trend toward the reduction of TNF-! and increase in
vitamin D and adiponectin was detected. All clinical parameters of periodontitis showed
improvement after periodontal therapy. In addition, levels of the periodontal pathogens T.
forsythia, T. denticola and P. gingivalis were considerably reduced after treatment. Although
the periodontitis population in the present study included smokers and smoking is a
recognized risk factor for periodontitis, clinical and microbiological improvements could be
achieved.

DISCUSSION

NIH-PA Author Manuscript

The primary goal of this exploratory study was to examine relationships among serum levels
of IL6, TNF-!, adipokines, vitamin D and clinical and microbial parameters of chronic
periodontitis. The secondary objective of the present investigation was to assess the effects
of therapy on the levels of those serum analytes before and after non-surgical periodontal
therapy. We hypothesized that periodontal infection and inflammation might affect systemic
levels of adiponectin, leptin, resistin, IL-6 and TNF-!, which can influence and/or promote
other systemic conditions, such as insulin resistance and metabolic syndrome. In that case,
periodontal treatment could directly affect not only the oral cavity, but systemic health as
well. In addition, clinical and microbial periodontal parameters and the serum analytes
selected for study could be influenced by systemic levels of vitamin D due to its proposed
anti-inflammatory properties
Serum Levels of Adiponectin, Leptin, Resistin, IL-6 and TNF-! at Baseline
Even though elevated levels of IL-6 and TNF-! have been reported in periodontitis patients,
both locally 36, 37 and systemically 8, 9, 12-15, we did not find a dose-response association
between serum levels of analytes and severity of periodontitis (Table 2). Although no
relationship was observed among periodontal parameters and serum analytes, we observed a
strong positive correlation between IL-6 and leptin (Fig. 1). This relationship has been
reported previously 30 and supports the pro-inflammatory role of those serum analytes. We
also found a positive correlation between adiponectin and vitamin D, two proposed antiinflammatory mediators. In addition, negative correlations were found between vitamin D
and both IL-6 and leptin, supporting their proposed antagonistic roles in inflammation.
J Periodontol. Author manuscript; available in PMC 2013 September 01.
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Few studies have reported on the association between adipokines and periodontal diseases.
Saito et al (2008)23 observed higher serum levels of resistin, but not adiponectin in Japanese
women with periodontitis. The authors proposed that the increase in circulating levels of
resistin might be due to the local involvement of monocytes and macrophages in periodontal
inflammation. However, in our study, patients presented even higher mean % BOP and
resistin was not associated with any of the periodontal parameters. Furugen et al (2008)24
observed higher levels of resistin in Japanese elders with periodontitis, when compared with
periodontally healthy elders. This finding is in contrast with our results, possibly due to
differences in age, BMI and ethnic characteristics. Similar to our results, those authors found
that circulating adiponectin was associated with gender, as higher levels of adiponectin were
observed in females, but was not associated with periodontal parameters. They suggested
that different isoforms of adiponectin - low, middle and high molecular weight - might exert
different effects, which would not have been detected in previous studies, as well as in ours,
since only total adiponectin was evaluated. Even though the role of those isoforms is not
fully understood, Nagano et al (2011)38 observed that the high molecular weight adiponectin
to total adiponectin ratio was significantly lower in subjects with periodontal pockets.
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Infections lead to increased circulating leptin 39, a suggested risk factor for cardiovascular
disease 40. Karthikeyan & Pradeep (2007)25 found an association between high serum leptin
and severity of periodontitis and detected mean serum leptin levels of 12,082 pg/ml in
periodontitis patients, which was above the level that is considered a risk factor for
cardiovascular disease (10,000 pg/ml).41 In the present study, we did not find an association
between serum leptin and severity of periodontitis. At baseline, we detected a mean leptin
level of 11,970 pg/ml, which is comparable to levels from the Karthikeyan & Pradeep
study.25 This mean level remained virtually unchanged after periodontal treatment, even
though periodontal infection and inflammation were successfully controlled.
A positive association between systemic levels of TNF-! and periodontitis has been
reported.9, 12, 14, 15, 28, 42 Duarte et al (2010)28 found higher TNF-! in generalized
aggressive periodontitis (GAgP) patients than in generalized chronic periodontitis (GCP)
patients and healthy subjects (H), although no differences were observed between GCP and
H. Passoja et al 14 showed that chronic periodontitis patients presented higher circulating
levels of TNF-! than periodontally healthy subjects. However, when subjects were
categorized into tertiles according to severity of periodontitis, no significant differences
were observed. Conversely, other authors have failed to demonstrate this
association. 8, 9, 23, 24, 43 A similar scenario exists for IL-6, in which a positive association
with periodontitis has been shown by some investigators 8, 9, 12, 15, 28, but not
others.23, 24, 27, 30
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In the present study, we did not find associations between circulating TNF-! and IL-6 and
any of the periodontal parameters (Fig. 2, Table 2), including the subgingival microbiota.
This is in accord with Bretz et al (2005)12 who did not find an association between
periodontal pathogens assessed by BANA and levels of IL-6 and TNF-!.
Because adiponectin, resistin, leptin, IL-6 and TNF-! have such an important role in
inflammation, the population was subset into tertiles according to levels of those analytes.
We hypothesized that a worse periodontal status would account for the higher levels of a
few of those biomarkers, including IL-6, TNF-! and leptin. However, there was no
difference among tertiles for any of the analytes or any of the clinical or microbiological
parameters analyzed. In fact, analysis showed a greater influence of gender and BMI on the
levels of most of the serum analytes than any clinical or microbial parameter of periodontitis
(Table 3).

J Periodontol. Author manuscript; available in PMC 2013 September 01.

TELES et al.

Page 7

NIH-PA Author Manuscript

It should be noted that most of the studies cited above compared serum samples from
periodontitis and periodontally healthy individuals. In the present study, we compared levels
of serum analytes in periodontitis patients with different levels of disease severity and
bacterial load. It should also be highlighted that differences in the study population,
including the extent and severity of periodontitis, as well as the methods of detection of
analytes, and the wide range of levels of the serum markers may contribute to the lack of
consensus in the literature cited above.
Levels of Vitamin D at Baseline
Vitamin D has an important role in calcium homeostasis, bone growth and preservation. It
has been shown to inhibit antigen-induced T cell proliferation and cytokine production 44,
acting as an immunomodulatory agent.45
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Recently, vitamin D has been proposed to also have anti-inflammatory properties. Analyzing
6,700 subjects, Dietrich et al (2005)31 found that individuals in the highest quintile of serum
vitamin D presented significantly less bleeding, lower mean pocket depth and clinical
attachment loss, number of missing teeth and BMI. It has also been suggested that vitamin D
(and calcium) supplementation may have a positive effect on periodontal health, particularly
on bleeding on probing, gingival index and PD.46, 47 Interestingly, polymorphisms in
vitamin D receptors have been linked to generalized aggressive periodontitis (GAgP)48 and
severe chronic periodontitis 49. Our results are in accord with those of Dietrich et al
(2005)31. The highest levels of circulating vitamin D were detected among the individuals
that presented less bleeding on probing, lower mean PD, CAL and number of missing teeth,
as well as levels of pathogenic bacteria. In addition, the proposed anti-inflammatory role of
vitamin D was supported in this study by its positive correlation with adiponectin and
negative correlation with IL-6 and leptin.
Effects of Treatment on Serum Analytes, Clinical Parameters and Subgingival Bacteria
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Intervention studies have been performed in order to assess whether periodontal therapy can
influence serum levels of pro- and anti-inflammatory mediators, with conflicting results.
Marcaccini et al (2009)15 showed significantly lower serum IL-6 in chronic periodontitis
patients after non-surgical periodontal treatment. Similar results have been reported by
others.9, 26 Duarte et al (2010)28 found that non-surgical periodontal therapy reduced levels
of TNF-! in GAgP, but not chronic periodontitis patients. Shimada et al (2010)30 found
significant reduction in circulating leptin after the treatment of periodontitis patients.
However, others did not find significant differences in post-therapy circulating levels of
TNF-! 9, 27 or IL-6 27, despite positive changes in clinical periodontal parameters. In the
present study, we demonstrated improvement in all clinical and microbial parameters of
periodontitis. However, virtually no differences were detected in the levels of any of the
serum analytes post-therapy. The lack of consensus in the current literature regarding the
systemic effects of periodontal therapy might be due to factors already discussed above and
may also include the presence of systemic risk factors and co-morbidities. Studies that
detected effects on serum analytes focused on patients with severe and/or generalized forms
of periodontitis 26, 28, on patients at risk for systemic diseases, such as cardiovascular
diseases 29 or subjects who presented with other modifying factors, such as diabetes.50
Hence, it is possible that those individuals presented an infectious/inflammatory burden that
surpassed the burden elicited solely by moderate chronic periodontitis.
Our findings suggest that chronic periodontitis might play a minor role, if any, in serum
levels of inflammatory mediators in systemically healthy subjects. The influence of gender
and BMI outweighted any potential role that local periodontal infection and inflammation
may have on systemic markers of inflammation in the absence of generalized periodontitis
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or systemic modifying factors. Even though there is controversy on the direct impact of
periodontal therapy on systemic inflammation, there is consensus regarding the clinical and
microbiological benefits of periodontal therapy. Therefore, any positive systemic effect that
might occur as consequence of periodontal treatment would be a welcome bonus to the
essential role of treatment in maintaining the periodontal tissues.
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Summary sentence
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Chronic periodontitis might play a minor role in serum levels of inflammatory mediators
in systemically healthy subjects. The influence of gender and BMI seems to outweighted
the potential role that local periodontal infection and inflammation may have on systemic
markers of inflammation in the absence of generalized periodontitis or systemic
modifying factors.
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Figure 1.

Plot of mean levels of adiponectin, leptin, resistin, IL-6, TNF-! and vitamin D in 56 chronic
periodontitis patients (Vitamin D: n=21 patients). Each circle represents values for a single
subject. Regression lines were fit to pairs of serum analytes and correlation coefficients are
indicated in the panel (r). Red panels represent statistically significant positive correlations
and turquoise panels represent statistically significant negative correlations (p<0.01, t>2.678
and p<0.001 t>3.496). Amounts of TNF-! were below the detection level in 4 of the
subjects and were recorded as zero.
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Figure 2.
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Bar plots of mean serum analytes, mean periodontal clinical parameters and mean counts of
red complex species (Porphyromonas gingivalis, Treponema denticola and Tannerella
forsythia) (Socransky et al 1998)35 in subgingival plaque before (red bars) and after
periodontal treatment (yellow bars). Due to the number of bacterial species evaluated, only
those that presented difference in pre and post- treatment levels with an associated p
value<0.05 were included in the figure. The bars represent values for each serum analyte,
clinical parameter and bacterial species averaged within each subject and then averaged
across subjects at each time point separately. The whiskers represent the standard error of
the mean. Note that y axis values differ for each panel. Significance of differences between
time points was sought using the Wilcoxon signed ranks test. Amounts of TNF-! were
below the detection level in 1 of the subjects at baseline and was recorded as zero.
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Table 1

Clinical and serum analytes characteristics of the study population at baseline (n=56).
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Clinical Features

Median

IQR

Plaque

64

32

Gingival Redness

67

32

BOP

29

25

% sites with

0

1

PD (mm)

3.1

0.9

AL (mm)

Suppuration

3.4

1.5

N missing teeth

2

4

BMI (kg/m^2)

26

6

Mean% Males

53

Mean%Current Smokers

49
49.5

Age (years)

14.6

NIH-PA Author Manuscript

Analytes
Adiponectin (#g/mL)

3.9

3.5

Leptin (ng/mL)

7.7

10.7

Resistin (ng/mL)

7.3

4.7

IL-6 (pg/mL)

2.3

1.8

TNF-! (pg/mL)

1.0

1.2

Vitamin D (ng/mL)

26.0

15.0

Note: Levels of vitamin D represent samples from 21 subjects. Four of the subjects presented amounts of TNF-! were below the detection level. In
these subjects TNF-! levels were recorded as zero.
Reference values for serum analytes: Adiponectin: unknown; Leptin: 2.3 – 11.1 ng/mL ( for BMI 18-25), Resistin: 6.39 – 26.4 ng/mL; IL-6: :
0.5-1500pg/mL; TNF-!: : 0.55 – 2.816 pg/mL; Vitamin D: 9-37.6 ng/mL (data provided by HCCL and the assays’ manufacturers):
IQR: Interquartile range
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0.2
1.1
5
8.1

2.6
2.6
1.5
26.5
44
28
52.4

PD (mm)

AL (mm)

N missing teeth

BMI (kg/m^2)

Mean % Males

Mean %Current Smokers

Age (years)
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10.9
5.6
2.0
1.3
5.5

7.9
7.6
2.5
0.9
29.8

Leptin (ng/mL)

Resistin (ng/mL)

IL-6 (pg/mL)

TNF-! (pg/mL)

Vitamin D (ng/mL)

0.8
0.8
0.6
0.2

0.5
0.7
0.5
0.5

T. forsythia

P. gingivalis

T. denticola

P. intermedia

Bacterial Species (× 10^5)

3.3

3.6

Adiponectin (#g/mL)

Analytes

40
52.4

0

0

Suppuration

1.5

0.8

1.7

1.5

25.2

1

2.3

7.2

9

4.1

15.9

50

21

20

BOP

1.6

1.9

1.4

1.9

17.4

1.2

1.2

3.4

14.4

3.5

2.3

1.2

0.9

2.2

25

1.0

2.1

7.4

6.4

3.7

26.5

2

3.4

3.1

0

30

68

30

57

Gingival Redness

66

19

23

18

<3.4

Median

49

N=

<2.8

IQR

Plaque

% sites with

Pocket Depth (mm)

Median

2.2

4.2

4.2

3.3

17

0.6

1.7

4.2

4.5

3.8

13.9

5.3

4

1.0

0.3

2

20

34

29

IQR

0.0003

0.05

0.012

0.003

p value

0.577

0.755

0.507

0.923

0.337

0.821

p value

46.8

80

70

25.9

4

4.7

3.9

0

48

69

81

19

≥3.4

Median

11.1

4.6

5

1.2

0.7

2

29

15

25

IQR

0.348

0.009**

0.353**

0.892

0.266

0.0001

0.0001

0.125

0.0001

0.097

0.003

p value

Kruskall-Wallis

Median and interquartile ranges (IQR) for serum analytes, clinical and microbial parameters subset according to pocket depth.
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0.3

0.1

E. nodatum

0.5

0.8

2.0
0.7

1.5
1.0

2.1
0.0003

0.005

p value

*Chi-square analysis.

Note: Levels of vitamin D represent samples from 21 subjects. Four of the subjects presented amounts of TNF-! were below the detection level. In these subjects, TNF-! levels were recorded as zero. Due
to the number of bacterial species evaluated, only those that presented differences with associated p values<0.05 were included in the table.

0.9

1.1
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0.5
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P. nigrescens
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Bacterial Species (× 10^5)
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0.9

N=

18
8.3

4.4

6

<27.9

20

<24.4

5.5

3.5

1.8

SD

21.9

18

<63.1

26

20.2

18

<9.0

32.7

28

3.6

19

<95.2

28

18

<13.2

Mean

20.4

20.7

8.9

2.1

SD

‡

‡

0.0005

0.017

*

‡

0.003

0.0001

0.003

*

‡

0.02

*

0.024

p value
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Kruskall-Wallis analysis.

Chi-square analysis

‡

*

Note: All serum, clinical and microbial parameters were included in the analysis. Due to the high number of variables evaluated, only those that presented differences with associated p values<0.05 were
included in the table.

Leptin

BMI

67

%Male

67

8

6.0

7.5

Leptin

<2.7
20

<1.7
18

N=

25.6

23.7

BMI

IL-6 (pg/mL)

47

83

%Male
3.5

2.6

2.0

IL-6

<10.6

58

72
<5.4

20

<5.4

Mean

19

N=

SD

18

< 3.1

Mean

18

Leptin (ng/mL)

%Male

N=

Adiponectin (#g/mL)

Mean (± SD) serum analytes, BMI and percentage of males, according to levels of serum analytes.
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